FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The US Food and Drug Administration is considering limiting future Covid-19 vaccine approvals, to adults aged 65 and older, and those with underlying health conditions that increase their risk of ...